Samuel Kyle

Improved specificity with 68Ga PSMA PET/CT to detect clinically significant lesions “invisible” on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology

Peter Donato, Matthew J. Roberts, Andrew Morton et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 110 citations · Full text

Medicine, Nuclear Medicine, Radiology +14

68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer

Matthew J. Roberts, Andrew Morton, Peter Donato et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 107 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is 68Ga-PSMA PET/CT guided biopsy the future?

Peter Donato, Andrew Morton, John Yaxley et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 97 citations · Full text

Medicine, Oncology, Urology +14

The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison

Arsalan Tariq, Michael Kwok, Adam Pearce et al. · Urologic Oncology Seminars and Original Investigations · 2021 · 32 citations

Medicine, Oncology, Radiology +17

Characterization of tumor thrombus in renal cell carcinoma with prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT)

Arsalan Tariq, Stephen McGeorge, Adam Pearce et al. · Urologic Oncology Seminars and Original Investigations · 2022 · 17 citations

Medicine, Nuclear Medicine, Oncology +17